This evidence shows that via activation of NF-κB, which promotes the production of pro-inflammatory cytokines and causes hyperglycaemia and hyperlipidaemia, the PKC/ERK pathway can induce cardiac and vascular inflammation. This evidence concerns the gene MAPK1 and Hyperglycemia.